A randomized, crossover trial of one night of oxygen therapy for obstructive sleep apnea in patients with fibrotic interstitial lung disease
Sleep and Breathing · 2025
DOI: 10.1007/s11325-025-03251-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Teng Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Oxygen Inhalation Therapy, Lung Diseases, Interstitial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: High-level Hospital Construction Project of Guangdong Provincial People's Hospital.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: There is no satisfactory treatment for obstructive sleep apnea (OSA) in patients with interstitial lung disease (ILD) because of poor tolerance of positive airway pressure (PAP) therapy. Supplemental oxygen therapy has been shown to reduce hypoxemia and is well tolerated in patients with ILD. However, little is known about the effect of nocturnal oxygen supplementation (NOS) on OSA in patients with ILD. In this study, we evaluated one night of oxygen therapy in ILD patients with OSA. METHODS: Forty-one patients with fibrotic ILD and OSA were randomized to receive supplemental oxygen or air for one night each in a crossover design separated by a washout period of one week. Polysomnography was performed, and sleep-disordered breathing, nocturnal desaturation, sleep architecture, and cardiovascular reactions were monitored. RESULTS: During nights with sham oxygen, the median (interquartile range) apnea-hypopnea index (AHI) was 14.1/h (10.4/h-24.1/h). The percentage of patients in the N3 sleep stage (N3%) was 19.5% (14.0-31.2%). NOS significantly decreased the AHI by a median of 9.3/h (95% CI, 7.6/h-14.4/h; P < 0.001), increased N3% by 4.4% (95% CI, 0.3-10.1%; P = 0.049), and lowered the sleep stage change index by 1.6/h (95% CI, 0.0/h-4.8/h; P = 0.036). NOS improved the oxygen desaturation index (ODI) by -8.8/h (95% CI, -13.4/h to -5.9/h; P < 0.001) and the mean SpO2 by 3.0% (95% CI, 2.6-4.5%; P < 0.001). The mean heart rate during sleep was reduced with the NOS; however, total sleep time and nocturnal blood pressure did not change. CONCLUSIONS: In patients with OSA and ILD, one night of oxygen therapy significantly improved sleep-disordered breathing, sleep architecture, nocturnal oxygenation, and heart rate. NOS may be a therapeutic option for ILD patients with OSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
- National Center for Respiratory Medicine, Beijing, China.
- Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- National Clinical Research Center for Respiratory Diseases, Beijing, China.
- State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China. yutian728@sina.com.
Förderung
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital
Zitieren
APA
Han, T., Xiang, B. Y., Liu, Z. L., Guo, X. R., Mao, L. S., Liu, X., Li, Y. M., & Zhang, X. L. (2025). A randomized, crossover trial of one night of oxygen therapy for obstructive sleep apnea in patients with fibrotic interstitial lung disease. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03251-0
Vancouver
Han T, Xiang BY, Liu ZL, Guo XR, Mao LS, Liu X, et al. A randomized, crossover trial of one night of oxygen therapy for obstructive sleep apnea in patients with fibrotic interstitial lung disease. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03251-0
BibTeX
@article{Han2025,
author = {Han, Teng and Xiang, Bo Yun and Liu, Ze Long and Guo, Xin Rui and Mao, Lu Si and Liu, Xin and Li, Yi Ming and Zhang, Xiao Lei},
title = {A randomized, crossover trial of one night of oxygen therapy for obstructive sleep apnea in patients with fibrotic interstitial lung disease},
journal = {Sleep and Breathing},
year = {2025},
doi = {10.1007/s11325-025-03251-0}
}
EUVIMED